Performance

CRSP -9.22%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
CRSP	-0.06%	-4.58%	-9.22%	-11.10%	-28.18%	0.05	0.00%

Summary

CRSP at a glance

CRSP returned -9.22% over the past year and -11.10% a year over five years. Its worst drop in that year was -28.18%, smaller than 62% of stocks on Redstone, and its Sharpe ratio of 0.05 beats 29% of stocks on Redstone. It pays no dividends.

Ranking

How CRSP ranks

Current Drawdown

-19.15%

Rolling Volatility

48.93%

Actions

Metrics

Risk Indicators

Alpha-14.62%

Beta1.77x

Sharpe0.05

Sortino0.07

Omega1.01

Calmar-0.33

Martin0.20

Profile

About CRSP

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics.

Sector: Health Care
Industry: Biological Products, (no Diagnostic Substances)
Market cap: $4.9B
Listed: Oct 2016
Employees: 393
Headquarters: Zug
Website: crisprtx.com

Comparisons

CRSP: CRISPR Therapeutics AG

CRSP at a glance

How CRSP ranks

Current Drawdown

Rolling Volatility

About CRSP

Related comparisons